Introduction/Overview
Natural products have always been an important source of innovative drug discovery, and their structural diversity and wide range of biological activities provide valuable lead compounds for the treatment of various diseases. Coumarin compounds, as an important family of natural products, have attracted much attention due to their significant pharmacological activities such as anti-inflammatory, anti-tumor, and antioxidant effects. Pimpinellin, also known as 5,6-dimethoxy-2H-1-benzopyran-2-one, is a typical derivative of furan coumarin with a CAS number of 131-12-4. Early research mainly focused on its plant origin, as it is known to exist in various plants such as the Umbelliferae and Rutaceae families, such as the rhizomes of the traditional Chinese medicine Cyromium fortunei (J.) Smith. In recent years, with the deepening of pharmacological research, the anti-tumor activity of anise lactone, especially its ability to induce cell apoptosis and inhibit tumor cell growth, has been preliminarily confirmed. More notably, it exhibits multi-target and multi pathway anti-inflammatory potential, involving key inflammatory signaling molecules such as IL-6, STAT3, NF - κ B, indicating its broad application prospects in the treatment of inflammation related diseases such as rheumatoid arthritis, neuroinflammation, pain, etc. This article aims to systematically review the chemical properties, plant sources, pharmacological activities, molecular mechanisms of action, and medicinal properties of anise lactone, and to provide prospects for its future research and development directions.
Chemical structure and physicochemical properties
The molecular formula of anise lactone is C13H10O5, with a molecular weight of 246.2180. Its core structure is benzo [a] - pyranone (coumarin nucleus), with a methoxy group (- OCH3) attached to the 5th and 6th positions of the benzene ring, and a specific substitution pattern on the furan ring. It belongs to linear furan coumarins. This structure endows it with unique physicochemical properties and biological activity.
From the perspective of pharmacological parameters, the lipid water partition coefficient (LogP) of aniside is 1.8631, indicating its moderate lipophilicity and favorable transmembrane transport. The topological polar surface area (TPSA) is 61.81 Å ², relatively low, which is related to the fact that oxygen atoms in the molecule mostly exist in the form of ether bonds. Its water solubility is poor, about 0.0199 mg/mL, which may be a limiting factor for its oral bioavailability. It is worth noting that the predictive model shows a high blood-brain barrier (BBB) penetration ability, which provides potential advantages for its application in central nervous system related diseases such as neuroinflammation and brain tumors. In early safety indicators, the hERG channel inhibition risk of anisetin was negative, indicating a low potential risk of causing QT interval prolongation in the heart. However, the actual Ames test value is 1.5, although it is not clearly positive, it suggests that there may be slight mutagenic signals under specific conditions, and further evaluation through more comprehensive genetic toxicity tests is needed in subsequent development.
Plant sources and extraction methods
Anisetine is relatively widely distributed in nature, mainly found in plants of the Apiaceae and Rutaceae families. In the field of traditional Chinese medicine, an important source is the fern plant Cyrtomium fortunei J. Sm., whose dried rhizomes are commonly used for clearing heat, detoxifying, and deworming. In addition, it has also been detected in the skin of traditional medicinal plants such as anise (Pimpinella genus), Peucedanum praeruptorum Dunn, and citrus plants.
Organic solvent extraction is commonly used to extract anise from plant materials. Due to its moderate polarity, commonly used solvents include methanol, ethanol, ethyl acetate, chloroform, etc. The typical extraction process is to heat reflux or ultrasound assisted extraction of dried and crushed plant materials (such as Guanzhong rhizomes) with an appropriate solvent (such as 95% ethanol), combine the extraction solutions, and concentrate under reduced pressure to obtain the extract. Subsequently, separation and purification were carried out using methods such as silica gel column chromatography, preparative thin-layer chromatography, or high-performance liquid chromatography (HPLC). Taking silica gel column chromatography as an example, gradient elution systems such as petroleum ether ethyl acetate or chloroform methanol are commonly used to collect and enrich anise lactone based on its Rf value in specific polar solvent systems. The structure of the final pure product was confirmed by nuclear magnetic resonance (NMR, including 1H-NMR and 13C-NMR), mass spectrometry (MS), and comparison with standard samples. In recent years, green technologies such as supercritical CO2 extraction have also been explored for the extraction of such coumarin compounds to improve efficiency and reduce the use of organic solvents.
Pharmacological activity research
The pharmacological activity research of anise lactone has expanded from early antibacterial and antifungal fields to more complex anti-tumor and anti-inflammatory fields, among which anti-inflammatory activity is particularly prominent, involving multiple targets and pathways.
1. Anti inflammatory activity
This is currently the most active pharmacological direction of anise lactone research. Numerous in vitro and in vivo experiments have shown that anise lactone exhibits good inhibitory effects on both acute and chronic inflammation models.
* Regulation of inflammatory mediators Anisetine can significantly inhibit the excessive production of nitric oxide (NO) and prostaglandin E2 (PGE2) in macrophages (such as RAW264.7 cells) induced by stimuli such as lipopolysaccharide (LPS). Its mechanism of action is closely related to the inhibition of inducible nitric oxide synthase (iNOS/NOS2) and cyclooxygenase-2 (COX-2/PTGS2) expression.
* Inhibition of inflammatory cytokines Anisetine can dose dependently reduce the levels of key pro-inflammatory cytokines, including tumor necrosis factor - α (TNF - α), interleukin-6 (IL-6), and interleukin-1 β (IL-1 β). Inhibition of IL-1 β may involve regulation of inflammasome activation and caspase-1/CASP1 activity.
* The relieving effect on pain models Due to its anti-inflammatory properties and potential regulatory effects on pain sensing channels such as transient receptor potential vanillic acid subtype 1 (TRPV1) and anchoring protein subtype 1 (TRPA1), anisetin has shown analgesic effects in pain models such as acetic acid-induced writhing test and formalin test in mice.
* In vivo anti-inflammatory validation In acute inflammation models such as carrageenan induced paw swelling in rats and xylene induced ear swelling in mice, as well as chronic inflammation models such as Freund's complete adjuvant induced arthritis, administration of anisetin can effectively reduce tissue edema, inflammatory cell infiltration, and joint damage.
2. Antitumor activity
Anetholide has growth inhibitory activity on a variety of tumor cell lines (such as liver cancer, breast cancer, lung cancer, colon cancer cells), and its mechanism of action is mainly to induce apoptosis. Research has shown that anise lactone treatment can lead to tumor cell cycle arrest (such as G2/M phase), decreased mitochondrial membrane potential, increased intracellular reactive oxygen species (ROS) levels, and altered expression of apoptosis related proteins (such as Bax/Bcl-2 ratio and Caspase-3/9 activation), ultimately triggering cell apoptosis.
3. Other activities
In addition, studies have reported the antioxidant, antiviral (such as anti influenza virus), and neuroprotective activities of anise lactone, which are often associated with its anti-inflammatory effects.
Mechanism of action and molecular targets
The anti-inflammatory effect of anise lactone is not achieved through a single target, but through a complex network that inhibits two key pro-inflammatory signaling pathways, nuclear factor kappa B (NF - κ B) and signal transduction and transcription activator 3 (STAT3).
1. Inhibit the NF - κ B signaling pathway
NF - κ B is the core transcription factor of inflammatory response. LPS and other stimuli activate IKK complexes through Toll like receptors, leading to phosphorylation and degradation of I κ B α, causing nuclear translocation of NF - κ B (usually p50/p65 dimer), and initiating transcription of downstream inflammatory genes (such as TNF - α, IL-6, NOS2, PTGS2). Research has shown that anise lactone can inhibit the phosphorylation and degradation of I κ B α, thereby preventing the transfer of NF - κ B p65 subunit into the nucleus and ultimately downregulating the expression of a series of pro-inflammatory mediators. This is the main molecular basis for its broad-spectrum anti-inflammatory effect.
2. Inhibit the JAK/STAT3 signaling pathway
After IL-6 and other cytokines bind to their receptors, they activate the receptor associated tyrosine kinase JAK, which in turn phosphorylates and activates the transcription factor STAT3. Activated STAT3 forms dimers into the nucleus, promoting the expression of genes related to inflammation, cell proliferation, and survival. Anise lactone has been shown to inhibit the phosphorylation of STAT3 (including Tyr705 site), block its activation and nuclear translocation, thereby suppressing inflammation and tumor growth driven by the IL-6/STAT3 axis.
3. Regulating inflammasome activity
The assembly of inflammasomes (such as NLRP3) activates Caspase-1, leading to the cleavage, maturation, and release of IL-1 β and IL-18 precursors. The inhibitory effect of anise lactone on CASP1 suggests that it may intervene in the activation process of inflammasomes, thereby inhibiting the production of IL-1 β, a potent pro-inflammatory cytokine.
4. Affects other key targets
* Cyclooxygenase (COX)Directly or indirectly inhibit the expression and activity of COX-2 (PTGS2), and reduce PGE2 synthesis.
* Nitric oxide synthase (NOS)Inhibit the expression of iNOS (NOS2) and reduce excessive NO production.
* Pain related ion channels It may act as a regulator on TRPV1 and TRPA1 channels, which play a key role in inflammatory pain signaling, providing a mechanistic explanation for their analgesic activity.
In summary, anise lactone synergistically inhibits multiple key nodes of the inflammatory signaling pathway through multi-target action, forming a comprehensive anti-inflammatory network from upstream signal inhibition to downstream effector molecule reduction.
Evaluation of drug properties and pharmacokinetics
Although anise lactone has shown good pharmacological activity, its pharmacological properties still require systematic evaluation.
Pharmacokinetics (PK)Currently, there are few reports on pharmacokinetic studies of the anise lactone system. Based on its physicochemical properties (moderate LogP, low TPSA, high BBB penetration prediction), it can be inferred that it has good passive absorption in the small intestine after oral administration. However, its lower water solubility may lead to limited dissolution rate and absorption, affecting oral bioavailability. Coumarin compounds typically undergo extensive metabolism in the body, and the main metabolic pathways may include O-demethylation, hydroxylation, and subsequent glucuronic acid binding or sulfation reactions mediated by the hepatic microsomal cytochrome P450 enzyme system (CYP450). The key PK parameters such as metabolites, excretion pathways, and half-life need to be clarified through in vivo experiments.
Pharmacodynamics (PD)/Toxicology Its multi-target mechanism of action is pharmacological advantage, but it may also increase the risk of off target effects and potential toxicity. The preliminary data from Ames test (value of 1.5) suggests the need for more standardized genotoxicity combination tests (such as micronucleus test, chromosome aberration test) to clarify its genotoxicity risk. Although hERG inhibition is negative, a comprehensive cardiovascular safety evaluation is still needed. Long term subchronic and chronic toxicity studies, as well as reproductive toxicity assessments, are crucial for its preclinical development.
Formulation strategy In order to improve its water solubility and bioavailability, advanced formulation technologies can be explored, such as making cyclodextrin inclusion complexes, solid dispersions, nanocrystals, or lipid nanoparticles. These technologies can effectively increase drug solubility and stability, improve its absorption and distribution in vivo.
Clinical application prospects and prospects
The clinical application prospects of anise lactone mainly revolve around its strong anti-inflammatory and anti-tumor activities.
Potential indications：
1. Inflammatory diseases Given its inhibition of multiple pathways such as NF - κ B and STAT3, anisetin is expected to be developed for the treatment of chronic inflammatory diseases such as rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, and asthma. Its potential analgesic effect (through anti-inflammatory and regulation of TRP channels) also makes it a candidate drug for treating inflammatory pain.
2. tumor therapy As an apoptosis inducer, aniside can be used for anti-tumor therapy, especially for tumor types that are resistant to traditional chemotherapy drugs. Its anti-inflammatory effect also helps regulate the tumor microenvironment and enhance the efficacy of immunotherapy. Its high BBB penetration prediction gives it unique potential in the treatment of central nervous system tumors such as gliomas.
3. Neurodegenerative diseases Neuroinflammation is an important pathological link in diseases such as Alzheimer's disease and Parkinson's disease. The anti-inflammatory and neuroprotective effects of anise lactone, combined with its potential BBB penetration ability, provide possibilities for its application in this field.
Future research directions and challenges：
1. In depth mechanism research It is necessary to use chemical biology methods such as molecular docking, surface plasmon resonance, and photoaffinity labeling to accurately identify its direct target and elucidate the precise spectrum of its "multi-target" effects.
2. Optimization of drug properties in the system Comprehensive pharmacokinetics, metabolite identification, and toxicological evaluation are essential for advancing its preclinical research. The rational chemical modification based on structure-activity relationship (SAR) to improve its water solubility, metabolic stability, and potency, and reduce potential toxicity, is the focus of pharmaceutical chemistry research.
3. Explore combination therapy Studying the synergistic effect of anise lactone with existing anti-inflammatory or anti-tumor drugs may reduce their respective dosages, minimize side effects, and overcome drug resistance.
4. Clinical translational research After completing sufficient preclinical research, it is necessary to carefully design clinical trial protocols to verify their safety, pharmacokinetic characteristics, and efficacy in specific diseases in humans.
Conclusion
As a naturally occurring furan coumarin compound, anise lactone has demonstrated remarkable pharmacological activity in the fields of anti-inflammatory and anti-tumor effects due to its unique chemical structure and multi-target mechanism of action. It effectively regulates the complex inflammatory network and induces tumor cell apoptosis by synergistically inhibiting key signaling pathways such as NF - κ B and STAT3. Although it faces challenges such as water solubility and potential genetic toxicity in drug development, these challenges can be addressed through modern pharmaceutical chemistry, formulation studies, and toxicology research. With a deeper understanding of its mechanism of action and systematic preclinical development, anisetin is expected to evolve from a promising natural lead compound into an innovative drug candidate for the treatment of inflammation related diseases and tumors, contributing its value to human health. Future research should focus on target confirmation, drug efficacy optimization, and clinical translation to fully unleash the therapeutic potential of this natural molecule.
